The global Rare Genetic Diseases Testing Kit market size is anticipated to be at USD 790.9 Million in 2022 to USD 2487.53 Million in 2030 and exhibit a CAGR of 15.4% during the forecast period, 2023-2030.
Market Overview:
Genetic testing is a medical test that spots changes in genes, chromosomes, and proteins. Theoutput of a genetic test can confirm or rule out a suspected genetic disease or condition or help indetermining the chances of developing or passing on a genetic disorder through the family tree.Almost 77,000 genetic tests are currently in use, and others are being developed due to their high demand among people. The global rare genetic diseases testing kit market is primarily driven by the increasing prevalence of genetic disorders, advancements in the technological department associated with the genetic testing market, and the surging capital investments in research and development in the industry by the leading players in the market. At the present time, healthcare expenditure has risen across several developed and developing nations due to the awareness programs initiated by their respective governments and authorities in the region. These are anticipated to create a competitive edge for manufacturers to develop and introduce new and enhanced genetic testing kits in the market in the forthcoming years.
The COVID-19 pandemic emerged in China in December 2019, and since then, it has traversedglobally at a very rapid pace. China, Iran, Italy, Spain, the Republic of Korea, Germany, France,and the US are among the worst-affected countries in terms of the number of deaths reported.The COVID-19 outbreak has critically influenced industries in several countries due to lockdowns and shutdowns. The global healthcare sector faced serious disturbances such as supply chain disruptions, technology events, scarcity of employees and laborers, and office shutdowns as a result of this outbreak. It disturbed the overall growth in three major ways: bydisrupting production and demand, its financial hit on the manufacturing industry, and by supply-chain disruptions. Additionally, patients with undiagnosed rare diseases have also beenfacing several health challenges. These challenges include diagnostic and pro-diagnostic uncertainties intertwined with medical complexities resulting in poor health outcomes. Clinal trials have also been affected by the COVID-19 pandemic. It created several restrictions for clinical trials challenging the findings, recruitment, and retaining patients with rare disease conditions.
Market Drivers:
The increasing prevalence of genetic disorders among people is augmenting the demand for these testing kits market:
The rising cases of genetic disorders and the associated complication with it among people causesevere health problems that may be incompatible with life. According to various reports, genetic disorders and congenital abnormalities are as common as about 2% - 5% of all live births andaccount for around 30% of paediatric admissions in hospitals. Therefore, the increase in thenumber of these cases is driving the demand for rare genetic disease testing kits in the global market.
Increasing adoption of advanced technologies and surging R&D investments are boosting the market size:
The evolvement of next-generation sequencing (NGS), especially for the treatment of cancer,and various other chronic diseases shift the focus toward genomics-centric pharmacology. NSGprovides advantages such as precise accuracy, sensitivity, and speed compared to conventional methods and makes impactful changes to the field of oncology. Continuous scientific innovations have created new opportunities for the development of technologies that impact themanagement of disorders. Collaborations are being undertaken with various stakeholders involved, such as researchers, patients, and regulators, for rare disease product development. Increasing health awareness among people is driving the healthcare industry and
Propelling the rare genetic disease testing kit market:
An increase in the levels of health awareness among people has resulted in a rise in the numberof available registries and is one of the major driving forces of the industry. It enables a pool ofdata of a sufficient sample size for epidemiological and clinical research. They play an importantrole in evaluating the feasibility of clinical trials and thus enabling the effective planning ofclinical trials and the enrolment process. Registries speed up service planning along withsupporting public health and clinical research by providing necessary insights to researchers.Government initiatives and strategies supporting the developments in the industry arefostering the market size growth:The strategic government initiatives for new product development in rare disease diagnoses further augment the market growth. These initiatives incorporate products for the diagnosis, advancement of educational awareness, working towards the enlargement of research capitals inrare diseases, and opening the doors for expert societies with an aim of refining rare undiagnosed genetic disease patient care and supervision thus, expanding the market size globally.
Market Restraints:
The high installation cost associated with the devices and R&D in genetic testing ispredicted to hamper the global market growth: The high and plummeting costs associated with sequencing and genetic testing are likely to slowdown the growth of the global rare diseases testing kit market. Also, establishing a certain andspecific diagnosis for a genetic disorder is a major challenge in the healthcare sector and henceincurs a significant amount of cost to detect and diagnose it, de-escalating the market growth rate.This research report on the Rare Genetic Diseases Testing Kit Market has been segmentedand sub-segmented based on Type, Technology, Speciality, End-User, Region, and Companies.
RARE GENETICS DISEASES TESTING KIT MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
15.4% |
|
Segments Covered |
By Type, Technology, Speciality, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Thermo Fisher Scientific Inc., Invitae Corporation, Bio-Rad Laboratories, Inc. Perkin Elmer Inc., Illumina Inc .QIAGEN, F. Hoffmann-La Roche Ltd., Fulgent Genetics Myriad Genetics, Inc.Abbott, Eurofins Scientific, Sorenson Genomics, BIO-HELIX Biocartis, Cepheid (A subsidiary of Danaher) |
Diagnostic Testing
Prenatal Testing
New Born Screening
Predictive and Pre symptomatic Testing
Carrier Testing
Other Types
Based on type, the rare genetic diseases testing kit market has been segmented into 6 segments –Diagnostic Testing, Prenatal Testing, New Born Screening, Predictive and Pre symptomatic Testing, Carrier Testing, and Others.
Polymerase Chain Reaction
DNA Sequencing (NGS-Based Testing)
Whole Genome Sequencing
Microarrays
Fluorescence In Situ Hybridization (FISH)
Others
Based on technology, the rare genetic diseases testing kit market has been segmented into 6segments – Polymerase Chain Reaction, DNA Sequencing (NGS-Based Testing), WholeGenome Sequencing, Microarrays, Fluorescence in Situ Hybridization (FISH), and Others.The Next-Generation Sequencing (NGS) technology segment holds the maximum revenue shareof around 35% and dominates the segment in 2022. Wide-scale availability and rapid adoption ofNGS-based gene panels for cancer, neurologic disease, cardiovascular disease, paediatricconditions, and other genetic-related disease testing have driven the segment. Strategic initiatives by major players are anticipated to further augment the segment over the forecasted timeline.
Molecular Genetic Tests
Chromosomal Genetic Tests
Biochemical Genetic Tests
Based on speciality, the rare genetic diseases testing kit market has been segmented into 3 segments: Molecular Genetic Tests, Chromosomal Genetic Tests, and Biochemical GeneticTests. The molecular genetic tests segment dominates the global industry in 2022 and accounts for themaximum share of more than 41.00% of the global revenue. The segment will continue to retain its dominant position growing at the highest CAGR during the forecast period, 2023-2028. Anincrease in technological advancements and competence in handling & managing high-output ttechnologies within clinical arrangements are factors predicted to boost the segment growth.Furthermore, genome sequencing is the most advanced and unbiased testing method that is easilyavailable for both research and clinical purposes. This is primarily causing the declining costs ofsequencing tests along with the rapid development of next-generation sequencing-based new tests.
Hospitals
Clinics
Diagnostic Centers
Private Clinics
Laboratory Service Providers
Private Laboratories
Based on the end-user, the rare genetic diseases kit market has been segmented into 6 segments –Hospitals, Clinics, Diagnostic Centers, Private Clinics, Laboratory Service Providers, and Private Laboratories. The research laboratories segment is leading the global market in 2022 and accounts for the highest share of more than 46.90% of the overall revenue. They offer solutions based on various specialties, including molecular genetic tests, chromosomal genetic tests, and biochemical genetic tests.The diagnostic laboratories segment is anticipated to witness the fastest CAGR over the forecast period owing to the rising number of mergers and collaboration activities of diagnosticlaboratories with genetic testing companies.
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Based on regions, the rare genetic diseases testing kit market has been segmented into 5 major regions – North America, Europe, Asia-Pacific, South America, Middle-East, and Africa. North America is the major dominating region in the market in 2022, due to the increasing prevalence of genetic disorders amongst the population in the region. They are dominating therare genetic diseases testing kit market in terms of overall market share and market revenue and will continue to exert their dominance during the forecast timeline. This is due to genetic defects and chromosomal abnormalities in the population and rapid research and development processesboosting the market.
Rare Genetic Diseases Testing Kit Market – By Companies
Thermo Fisher Scientific Inc.
Invitae Corporation
Bio-Rad Laboratories
Inc .Perkin Elmer Inc.
Illumina Inc .QIAGEN
F. Hoffmann-La Roche Ltd.
Fulgent Genetics Myriad Genetics
Inc.Abbott Eurofins Scientific
Sorenson Genomics
BIO-HELIX Biocartis
Cepheid (A subsidiary of Danaher)
Recent key industry developments:
In June 2022, the U.S. FDA launched a 5-year strategy program for Rare Neurodegenerative Diseases, extending and improving the lives of people suffering fromrare diseases, by enabling patient access to innovative treatments.
In Feb 2022, Bionano Genomics launched an initiative, Rare Undiagnosed Genetic
Disease (RUGD) to help raise the level of dedication and focus in clinical and
translational research.
In December 2021, Thermo Fisher Scientific Inc., acquired PPD, Inc., a key global
supplier of clinical research services.
In June 2022, Avesthagen Ltd. formed a strategic partnership with Wipro Ltd. for the
popularization of its genetic testing offerings.
In November 2021, Genomenon and Alexion, AstraZeneca Rare Disease entered a
strategic partnership to make important information for the treatment and diagnosis of
rare diseases more easily accessible.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The global Rare Genetic Diseases Testing Kit market size is anticipated to be at USD 790.9 Million in 2022 to USD 2487.53 Million in 2030 and exhibit a CAGR of 15.4% during the forecast period, 2023-2030.
The global rare disease genetic diseases testing kit market is anticipated to grow at a CAGR of 15.4% from 2023 to 2030.
Next Generation Sequencing (NGS) dominates the testing kit market with a revenue share of 35% in 2023.
Some major players operating in the rare genetic diseases testing market include Quest Diagnostics, Perkin Elmer Inc., ARUP Laboratories, and Centogene.
Key factors that are fuelling the rare genetic diseases testing kit market growth include a crash in sequencing cost, growing patient registry for rare disease, & launch of new products and programs in rare genetic disease diagnosis
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
